How much funding has Synthorx raised?

Synthorx has raised $79.0M in total funding, most recently a Series C round.

Who are Synthorx's investors?

Synthorx's investors include Avalon Ventures, Sanofi Ventures, OrbiMed, RA Capital Management, Medicxi, Osage University Partners.

Where is Synthorx headquartered?

Synthorx is headquartered in San Diego, California, United States.

Synthorx

Acquired

San Diego, United States · Founded 2014 · $79.0M raised

Biotech

Headquarters: San Diego, California
Employees: 11–50
Founded: 2014
Business Model: B2B

Website: synthorx.com
Total Funding: $79.0M
Last Round: $63.0M Series CApr 2018
Rounds: 3

About

Synthorx was a La Jolla, California biotechnology company that used synthetic biology and a proprietary expanded DNA alphabet — an engineered base pair beyond the natural A, T, G, and C — to discover and develop novel protein therapeutics, diagnostics, and vaccines. Founded on research from Dr. Floyd Romesberg's lab at The Scripps Research Institute, the company was acquired by Sanofi in December 2019 for $2.5 billion.

Summary

Synthorx is a Biotech company based in San Diego, United States, founded in 2014. It has raised $79.0M in total across 3 rounds, most recently a $63.0M Series C round in Apr 2018. Investors include Avalon Ventures, Sanofi Ventures and OrbiMed.

LinkedIn X (Twitter)